Search bioRxiv⌕ Search

Biology subjects

Sasner, M. J.

Publications and source records attributed to Sasner, M. J..

6 recordsLinked to original sources

Humanized Klotho haplotypes cause widespread transcriptomic changes in mouse brain

Klotho KL is an aging factor that has been associated with Alzheimers Disease (AD) risk. Two common alleles circulate in human populations: the major allele FC and the minor allele VS, which is defined by two SNPs that cause two amino acid substitutions (F352V and C370S) in KLs second exon. To investigate the possibility that human KL variants influence brain aging and cognition, we developed a novel mouse model with humanized KL alleles. We used RNA-Seq to measure the whole brain transcriptome in four-and 12-month-old male and female C57Bl/6J mice carrying either the FC or the VS KL allele. We found that FC and VS carriers had widespread differences in gene expression in the brain at 12 months old, but not at four months old. The largest differences were in genes annotated to mitochondrial, ribosomal, and synaptic functions. Differential exon usage analysis identified differential splicing of synaptic genes, further supporting a role for KL on neuronal function. A more focused analysis of differential expression identified variation in glutamate receptors and amyloid precursor (APP) processing in particular, thereby linking human KL haplotypes to biological processes integral to AD pathogenesis. These results provide evidence that the human FC and VS KL haplotypes affect the function of the KL protein product in a manner that has widespread effects on gene expression in the brain and supports the hypothesis that these haplotypes may influence AD risk and pathogenesis.

genetics↗

Trem2*R47H and reduced TREM2 expression both mimic human Alzheimer's disease signatures in mice

INTRODUCTIONTREM2 loss of function variants are associated with late-onset Alzheimers disease (LOAD). We molecularly assessed mice with the missense variant, R47H (Trem2*R47HHSS), and mice with additional cryptic splicing and reduced Trem2 expression (Trem2*R47H) while comparing relevance to human LOAD. METHODSThe aberrant splice acceptor site in the Trem2*R47H mouse was humanized resulting in the Trem2*R47H humanized splice site (Trem2*R47HHSS) mouse. RNA sequencing was performed on mouse brain tissue and signatures were compared to human postmortem brain expression in LOAD cohorts. RESULTSTrem2*R47H mice had alternative splicing leading to reduced Trem2 expression; Trem2*R47HHSS mice expressed Trem2 at wild-type transcript and protein levels. Both models correlated with similar LOAD-associated signatures, and had similar effects on immune response, synapse, and vasculature biodomains. The Trem2*R47H model additionally affected extracellular matrix and myelination signatures. DISCUSSIONWe demonstrated that Trem2*R47H and Trem2*R47HHSS mice are complementary models for the study of molecular contributions to LOAD pathology.

neuroscience↗

WSB.APP/PS1 mice develop age-dependent cerebral amyloid angiopathy, cerebrovascular deficits, and white matter damage, which are modified by humanized APOE alleles.

INTRODUCTIONGrowing evidence suggests cerebrovascular deficits, including cerebral amyloid angiopathy (CAA), play a key role in Alzheimers disease (AD) pathogenesis. However, these facets of AD are not well understood, due in part to the lack of mouse models that develop robust vascular deficits and CAA. Here, we characterize human-relevant cerebrovascular phenotypes in WSB.APP/PS1 mice with and without humanized APOE alleles. METHODSAD-relevant cerebrovascular phenotypes in WSB, WSB.APP/PS1, WSB.APOE2/2APP/PS1, WSB.APOE3/3APP/PS1, and/or WSB.APOE4/4APP/PS1 mice were characterized using immunohistochemistry, transcriptomics, positron emission tomography/computed tomography, and ex-vivo analyses. RESULTSWSB.APP/PS1 mice exhibited age-related plaque deposition and CAA, significant transcriptomic overlap with human AD, myelin deficits, cerebrovascular/metabolic uncoupling, and altered cerebrovascular morphology. Aged WSB vasculature retained vasoreactivity, but exhibited increased stiffness. Compared to APOE2, APOE4 expression in WSB.APP/PS1 mice increased CAA and plaque-associated microglial area. DISCUSSIONThese data illustrate the utility of the WSB genetic context to model CAA and uncover vascular contributions to AD. HighlightsO_LIWSB.APP/PS1 mice developed CAA with age. C_LIO_LITranscriptomic profiling revealed significant molecular overlap between human AD and WSB.APP/PS1 brains. C_LIO_LITranscriptomics and immunofluorescence suggested age-related myelin deficits in WSB.APP/PS1 brains. C_LIO_LIWSB.APP/PS1 brains exhibited neurovascular uncoupling, changes in vascular volume and surface area, and increased permeability changes. C_LIO_LIWSB.APP/PS1 cerebrovasculature was resilient to loss of responsivity with age but exhibited increased vascular stiffness. C_LIO_LIHumanized APOE {varepsilon}4 alleles significantly increased CAA and parenchymal plaque-associated microglial area in WSB.APP/PS1 mice. C_LI Research in ContextO_LISystematic review: The authors characterized WSB.APP/PS1 as a unique human-relevant model of Alzheimers Disease and explored several facets of cerebrovascular deficits. C_LIO_LIInterpretation: WSB and/or WSB.APP/PS1 mice exhibited human-relevant vascular phenotypes, including CAA, neurovascular uncoupling, increased vascular tree volume, vascular stiffness, and resilience to age-related loss of responsivity. Furthermore, the transcriptomic profile of WSB.APP/PS1 brains significantly overlaps with signatures observed in human AD. WSB.APP/PS1 brains exhibited myelin deficits with age. Furthermore, humanized APOE {varepsilon}2, {varepsilon}3, and {varepsilon}4 alleles significantly modified WSB.APP/PS1 susceptibility to CAA, plaque deposition, and plaque-associated microglial area. C_LIO_LIFuture Directions: The WSB genetic context will be leveraged to identify specific molecular mechanisms associated with cerebrovascular deficits in AD. C_LI

neuroscience↗

Metabolomics profiling reveals distinct, sex-specific signatures in the serum and brain metabolomes in the mouse models of Alzheimer's disease

Structured AbstractO_ST_ABSINTRODUCTIONC_ST_ABSIncreasing evidence suggests that metabolic impairments contribute to early Alzheimers disease (AD) mechanisms and subsequent dementia. Signals in metabolic pathways conserved across species provides a promising entry point for translation. METHODSWe investigated differences of serum and brain metabolites between the early-onset 5XFAD and late-onset LOAD1 (APOE4.Trem2*R47H) mouse models of AD to C57BL/6J controls at six months of age. RESULTSWe identified sex differences for several classes of metabolites, such as glycerophospholipids, sphingolipids, and amino acids. Metabolic signatures were notably different between brain and serum in both mouse models. The 5XFAD mice exhibited stronger differences in brain metabolites, whereas LOAD1 mice showed more pronounced differences in serum. DISCUSSIONSeveral of our findings were consistent with results in humans, showing glycerophospholipids reduction in serum of APOE4 carriers and replicating the serum metabolic imprint of the APOE4 genotype. Our work thus represents a significant step towards translating metabolic dysregulation from model organisms to human AD.

neuroscience↗

Characterizing Molecular and Synaptic Signatures in Mouse Models of Late-Onset Alzheimer's Disease Independent of Amyloid and Tau Pathology

Structured AbstractO_ST_ABSINTRODUCTIONC_ST_ABSMODEL-AD is creating and distributing novel mouse models with humanized, clinically relevant genetic risk factors to more accurately mimic LOAD than commonly used transgenic models. METHODSWe created the LOAD2 model by combining APOE4, Trem2*R47H, and humanized amyloid-beta. Mice aged up to 24 months were subjected to either a control diet or a high-fat/high-sugar diet (LOAD2+HFD) from two months of age. We assessed disease-relevant outcomes, including in vivo imaging, biomarkers, multi-omics, neuropathology, and behavior. RESULTSBy 18 months, LOAD2+HFD mice exhibited cortical neuron loss, elevated insoluble brain A{beta}42, increased plasma NfL, and altered gene/protein expression related to lipid metabolism and synaptic function. In vivo imaging showed age-dependent reductions in brain region volume and neurovascular uncoupling. LOAD2+HFD mice also displayed deficits in acquiring touchscreen-based cognitive tasks. DISCUSSIONCollectively the comprehensive characterization of LOAD2+HFD mice reveal this model as important for preclinical studies that target features of LOAD independent of amyloid and tau.

neuroscience↗

Plcg2M28L interacts with high fat-high sugar diet to accelerate Alzheimers disease-relevant phenotypes in mice

Obesity is recognized as a significant risk factor for Alzheimers disease (AD). Studies have supported the notion that obesity accelerates AD-related pathophysiology in mouse models of AD. The majority of studies to date have focused on the use of early-onset AD models. Here we evaluate the impact of genetic risk factors on late-onset AD (LOAD) in mice fed a high fat/high sugar diet. We focused on three mouse models created through the IU/JAX/Pitt MODEL-AD Center, LOAD1, LOAD1.Plcg2M28L and LOAD1.Mthfr677C>T. At 2 months of age, animals were placed on a high fat/high sugar diet (HFD) that induces obesity, or a control diet (CD) that does not, until 12 months of age. Throughout the study, blood was collected to assess cholesterol and glucose. Positron emission tomography/computed tomography (PET/CT) was completed prior to sacrifice to image for glucose utilization and brain perfusion. At the completion of the study, blood and brains were collected for analysis. As expected, animals fed the HFD, regardless of genotype or sex, showed a significant increase in body weight compared to those fed the CD. Glucose and cholesterol increased as a function of HFD as well. Interestingly, LOAD1.Plcg2M28L demonstrated an increase in microglia density as well as alterations in regional brain glucose and perfusion when on a HFD. These changes were not observed in LOAD1 or LOAD1.Mthfr677C>T animals when fed a HFD. Furthermore, LOAD1.Plcg2M28L but not LOAD1.Mthfr677C>T or LOAD1 animals showed transcriptomics correlations to human AD modules. Our results show HFD affects brain health in a genotype-specific manner. Further insight into this process may have significant implications in the development of lifestyle interventions for treatment of AD.

neuroscience↗